**5. Conclusions**

It is evident from the data given here that cyclodextrins due to their distinctive conelike structure and unique properties can provide an excellent option to address various issues regarding drug and its delivery. CDs have been introduced successfully in pharmaceutical industry because of their unique property of forming dynamic inclusion complexes, thus improving the solubility, dissolution, bioavailability, and release profile of numerous drugs. The effectiveness of different CDs in improving the therapeutic potential of drugs depends upon both the type of guest molecule and the CD as they can influence types of the complexes formed. According to Connor and Higuchi, complexes can be A-type, B-type, and even non-inclusion type, such as complex aggregation.

Apart from traditional drug delivery system, recent research on CD-based nanosystems has grown as the CDs are biocompatible and can nicely serve as the platform for the formulation and pharmacokinetic efficiency without raising the risks.
